MARSHALL & POPP, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical manufacturer.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jan 16, 2026

Bills named in this filing 2

Lobbying activity 1

Medicare/Medicaid

Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.